BindingDB logo
myBDB logout

33 articles for thisTarget

The following articles (labelled with PubMed ID or TBD) are for your review
PMIDDataArticle TitleOrganization
8360878 29 Quinoxaline N-oxide containing potent angiotensin II receptor antagonists: synthesis, biological properties, and structure-activity relationships.EBI Bristol-Myers Squibb Pharmaceutical Research Institute
8360871 86 Nonpeptide angiotensin II receptor antagonists. 2. Design, synthesis, and structure-activity relationships of 2-alkyl-4-(1H-pyrrol-1-yl)-1H-imidazole derivatives: profile of 2-propyl-1-[[2'-(1H-tetrazol-5-yl)-[1,1' -biphenyl]-4-yl]-methyl]-4-[2-(trifluoroacetyl)-1H-pyrrol-1-yl]-1H- imidazole-5-carEBI Warner-Lambert
1956044 115 Synthesis and structure-activity relationships of a novel series of non-peptide angiotensin II receptor binding inhibitors specific for the AT2 subtype.EBI Warner-Lambert
 54 4,5-Dihydro-4-oxo-3H-imidazo[4,5-c]pyridines: potent arylacetic acid-derived AT1 antagonists with improved affinity for the AT2 receptorEBI TBA
 42 Balanced AT1 and AT2 angiotensin II antagonists. II. Potent 5 α-hydroxyacid imidazolyl biphenyl sulfonylureasEBI TBA
 60 The SAR of 6-(N-alkyl-N-acyl)-2-propyl-3-[(2′-tetrazol-5-yl)biphen-4-yl)methyl]-quinazolinones as balanced affinity antagonists of the human AT1 and AT2 receptorsEBI TBA
 56 Potent triazolinone-based angiotensin II receptor antagonists with equivalent affinity for both the AT1 and AT2 subtypesEBI TBA
 134 Development of angiotensin II antagonists with equipotent affinity for human AT1 and AT2 receptor subtypes.EBI TBA
 46 Balanced angiotensin II receptor antagonists. I. The effects of biphenyl “ortho”-substitution on AT1/AT2 affinitiesEBI TBA
12643919 50 Discovery of 4'-[(imidazol-1-yl)methyl]biphenyl-2-sulfonamides as dual endothelin/angiotensin II receptor antagonists.EBI Bristol-Myers Squibb Pharmaceutical Research Institute
8515427 43 Multiple binding modes for the receptor-bound conformations of cyclic AII agonists.EBI Washington University
8258820 47 A novel series of selective, non-peptide inhibitors of angiotensin II binding to the AT2 site.EBI Dupont Pharmaceuticals
12593652 50 Non-peptide angiotensin II receptor antagonists: chemical feature based pharmacophore identification.EBI University of Innsbruck
10052967 2 Bicyclic tripeptide mimetics with reverse turn inducing properties.EBI Uppsala University
10579816 10 Angiotensin II analogues encompassing 5,9- and 5,10-fused thiazabicycloalkane tripeptide mimetics.EBI Uppsala University
9784100 5 Metabolites of the angiotensin II antagonist tasosartan: the importance of a second acidic group.EBI Wyeth-Ayerst Research
9083479 15 Design, synthesis, and biological activities of four angiotensin II receptor ligands with gamma-turn mimetics replacing amino acid residues 3-5.EBI Uppsala University
7636853 35 4-Diazinyl- and 4-pyridinylimidazoles: potent angiotensin II antagonists. A study of their activity and computational characterization.EBI Laboratori Guidotti
7608902 53 Sulfonylureas and sulfonylcarbamates as new non-tetrazole angiotensin II receptor antagonists. Discovery of a highly potent orally active (imidazolylbiphenylyl)sulfonylurea (HR 720).EBI Hoechst Roussel Pgu Cardiovascular Agents
8120871 19 Pyrido[2,3-d]pyrimidine angiotensin II antagonists.EBI Wyeth-Ayerst Research
2362273 16 Conformational restriction of angiotensin II: cyclic analogues having high potency.EBI G.D. Searle And